Sun, Weili <br/><br/>
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.  [electronic resource] 

 -  Journal of hematology & oncology  05 2018 
 - 61 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-018-0604-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Child<br/>Dendritic Cells--drug effects<br/>Female<br/>Hematologic Neoplasms--drug therapy<br/>Humans<br/>Interleukin-3 Receptor alpha Subunit--therapeutic use<br/>Recombinant Fusion Proteins--pharmacology